Literature DB >> 24995389

The brainstem pathologies of Parkinson's disease and dementia with Lewy bodies.

Kay Seidel1, Josefine Mahlke, Sonny Siswanto, Reijko Krüger, Helmut Heinsen, Georg Auburger, Mohamed Bouzrou, Lea T Grinberg, Helmut Wicht, Horst-Werner Korf, Wilfred den Dunnen, Udo Rüb.   

Abstract

Parkinson's disease (PD) and dementia with Lewy bodies (DLB) are among the human synucleinopathies, which show alpha-synuclein immunoreactive neuronal and/or glial aggregations and progressive neuronal loss in selected brain regions (eg, substantia nigra, ventral tegmental area, pedunculopontine nucleus). Despite several studies about brainstem pathologies in PD and DLB, there is currently no detailed information available regarding the presence of alpha-synuclein immunoreactive inclusions (i) in the cranial nerve, precerebellar, vestibular and oculomotor brainstem nuclei and (ii) in brainstem fiber tracts and oligodendroctyes. Therefore, we analyzed the inclusion pathologies in the brainstem nuclei (Lewy bodies, LB; Lewy neurites, LN; coiled bodies, CB) and fiber tracts (LN, CB) of PD and DLB patients. As reported in previous studies, LB and LN were most prevalent in the substantia nigra, ventral tegmental area, pedunculopontine and raphe nuclei, periaqueductal gray, locus coeruleus, parabrachial nuclei, reticular formation, prepositus hypoglossal, dorsal motor vagal and solitary nuclei. Additionally we were able to demonstrate LB and LN in all cranial nerve nuclei, premotor oculomotor, precerebellar and vestibular brainstem nuclei, as well as LN in all brainstem fiber tracts. CB were present in nearly all brainstem nuclei and brainstem fiber tracts containing LB and/or LN. These findings can contribute to a large variety of less well-explained PD and DLB symptoms (eg, gait and postural instability, impaired balance and postural reflexes, falls, ingestive and oculomotor dysfunctions) and point to the occurrence of disturbances of intra-axonal transport processes and transneuronal spread of the underlying pathological processes of PD and DLB along anatomical pathways.
© 2014 International Society of Neuropathology.

Entities:  

Keywords:  Parkinson's disease; alpha-synuclein; brainstem; dementia with Lewy bodies; prion-like disease

Mesh:

Substances:

Year:  2014        PMID: 24995389      PMCID: PMC4397912          DOI: 10.1111/bpa.12168

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  72 in total

Review 1.  Prevalence of oropharyngeal dysphagia in Parkinson's disease: a meta-analysis.

Authors:  J G Kalf; B J M de Swart; B R Bloem; M Munneke
Journal:  Parkinsonism Relat Disord       Date:  2011-12-03       Impact factor: 4.891

Review 2.  Beyond α-synuclein transfer: pathology propagation in Parkinson's disease.

Authors:  Christian Hansen; Jia-Yi Li
Journal:  Trends Mol Med       Date:  2012-04-13       Impact factor: 11.951

Review 3.  The Parkinson's complex: parkinsonism is just the tip of the iceberg.

Authors:  J William Langston
Journal:  Ann Neurol       Date:  2006-04       Impact factor: 10.422

Review 4.  Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders.

Authors:  Mathias Jucker; Lary C Walker
Journal:  Ann Neurol       Date:  2011-10       Impact factor: 10.422

5.  Substance P-containing neurons in the pontomesencephalic tegmentum of the human brain.

Authors:  G M Halliday; W P Gai; W W Blessing; L B Geffen
Journal:  Neuroscience       Date:  1990       Impact factor: 3.590

6.  Degeneration of ingestion-related brainstem nuclei in spinocerebellar ataxia type 2, 3, 6 and 7.

Authors:  U Rüb; E R Brunt; E Petrasch-Parwez; L Schöls; D Theegarten; G Auburger; K Seidel; C Schultz; K Gierga; H Paulson; C van Broeckhoven; T Deller; R A I de Vos
Journal:  Neuropathol Appl Neurobiol       Date:  2006-12       Impact factor: 8.090

Review 7.  Gastrointestinal dysfunction in Parkinson's disease.

Authors:  Ronald F Pfeiffer
Journal:  Lancet Neurol       Date:  2003-02       Impact factor: 44.182

8.  Mesopontine cholinergic neuron involvement in Lewy body dementia and multiple system atrophy.

Authors:  A M Schmeichel; L C Buchhalter; P A Low; J E Parisi; B W Boeve; P Sandroni; E E Benarroch
Journal:  Neurology       Date:  2008-01-29       Impact factor: 9.910

Review 9.  The neuropathology, pathophysiology and genetics of multiple system atrophy.

Authors:  Z Ahmed; Y T Asi; A Sailer; A J Lees; H Houlden; T Revesz; J L Holton
Journal:  Neuropathol Appl Neurobiol       Date:  2012-02       Impact factor: 8.090

10.  Brainstem: neglected locus in neurodegenerative diseases.

Authors:  Lea Tenenholz Grinberg; Udo Rueb; Helmut Heinsen
Journal:  Front Neurol       Date:  2011-07-11       Impact factor: 4.003

View more
  84 in total

1.  Direct In Vivo MRI Discrimination of Brain Stem Nuclei and Pathways.

Authors:  T M Shepherd; B Ades-Aron; M Bruno; H M Schambra; M J Hoch
Journal:  AJNR Am J Neuroradiol       Date:  2020-04-30       Impact factor: 3.825

2.  Parkinson-Associated SNCA Enhancer Variants Revealed by Open Chromatin in Mouse Dopamine Neurons.

Authors:  Sarah A McClymont; Paul W Hook; Alexandra I Soto; Xylena Reed; William D Law; Samuel J Kerans; Eric L Waite; Nicole J Briceno; Joey F Thole; Michael G Heckman; Nancy N Diehl; Zbigniew K Wszolek; Cedric D Moore; Heng Zhu; Jennifer A Akiyama; Diane E Dickel; Axel Visel; Len A Pennacchio; Owen A Ross; Michael A Beer; Andrew S McCallion
Journal:  Am J Hum Genet       Date:  2018-11-29       Impact factor: 11.025

Review 3.  Cellular and Molecular Aspects of Parkinson Treatment: Future Therapeutic Perspectives.

Authors:  Khosro Jamebozorgi; Eskandar Taghizadeh; Daryoush Rostami; Hosein Pormasoumi; George E Barreto; Seyed Mohammad Gheibi Hayat; Amirhossein Sahebkar
Journal:  Mol Neurobiol       Date:  2018-11-05       Impact factor: 5.590

4.  Progression of Dysphagia in Spinocerebellar Ataxia Type 6.

Authors:  Chiharu Isono; Makito Hirano; Hikaru Sakamoto; Shuichi Ueno; Susumu Kusunoki; Yusaku Nakamura
Journal:  Dysphagia       Date:  2017-01-02       Impact factor: 3.438

5.  Evaluating and Managing Sleep Disorders in the Parkinson's Disease Clinic.

Authors:  S Gulyani; R Salas; Z Mari; S Choi; A Mahajan; C Gamaldo
Journal:  Basal Ganglia       Date:  2016-05-27

6.  The serotonin aldehyde, 5-HIAL, oligomerizes alpha-synuclein.

Authors:  Yunden Jinsmaa; Adele Cooney; Patricia Sullivan; Yehonatan Sharabi; David S Goldstein
Journal:  Neurosci Lett       Date:  2015-01-28       Impact factor: 3.046

7.  Constitutive and Acquired Serotonin Deficiency Alters Memory and Hippocampal Synaptic Plasticity.

Authors:  Sebastian P Fernandez; Aude Muzerelle; Sophie Scotto-Lomassese; Jacques Barik; Agnès Gruart; José M Delgado-García; Patricia Gaspar
Journal:  Neuropsychopharmacology       Date:  2016-07-27       Impact factor: 7.853

8.  Parkinson disease and incidental Lewy body disease: Just a question of time?

Authors:  Diego Iacono; Maria Geraci-Erck; Marcie L Rabin; Charles H Adler; Geidy Serrano; Thomas G Beach; Roger Kurlan
Journal:  Neurology       Date:  2015-10-14       Impact factor: 9.910

Review 9.  Mesencephalic and extramesencephalic dopaminergic systems in Parkinson's disease.

Authors:  Fanni F Geibl; Martin T Henrich; Wolfgang H Oertel
Journal:  J Neural Transm (Vienna)       Date:  2019-01-14       Impact factor: 3.575

10.  Gait function and locus coeruleus Lewy body pathology in 51 Parkinson's disease patients.

Authors:  Kelly A Mills; Zoltan Mari; Catherine Bakker; Vanessa Johnson; Gregory M Pontone; Alexander Pantelyat; Juan C Troncoso; Olga Pletnikova; Ted M Dawson; Liana S Rosenthal
Journal:  Parkinsonism Relat Disord       Date:  2016-09-25       Impact factor: 4.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.